Head on over to Paul Knoepfler’s blog and check out hisYamanaka Interview on Clinical Use of Pluripotent Stem Cells.
I don’t know. I’ll be posting more about this tomorrow, but… suffice it to say right now that I wish I could get more excited about this new study with iPSC’s. I think they’re rushing wayyyyyy too fast to use these techniques on a human subject, especially when you look at all the pre-clinical problems and questions. And there were A LOT.
And I think we could have all lived without this quote:
At the same time, the ethical issues that hESC possess mean that as iPSC technology improves, hESC will be less needed. Still, iPSC is a new technology, and its safety and efficacy still needs to be confirmed.
Um, hello, EARTH TO DR. YAMANAKA. There ARE no “ethical issues.” Seriously, you don’t know about Robert Lanza’s blastomere technique, which doesn’t destroy the embryo?. And yep, no kidding that iPSC’s safety needs to be confirmed, much less their efficacy. Maybe we shouldn’t be blithely testing these cells on human beings right now.
That’s enough of a rant for today, but there will be more tomorrow!
I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.
That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.
I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Latest posts by Cathy Danielson (see all)
- A new story about shareholder determination! - January 21, 2016
- The Latest Thoughts on Why Ocata is Being Bought out by Astellas - November 29, 2015
- The Missing Word: Why we don’t have stem cell cures. - November 23, 2015